Bortezomib directly inhibits osteoclast function in multiple myeloma: implications into the management of myeloma bone disease
- PMID: 18614229
- DOI: 10.1016/j.leukres.2008.06.017
Bortezomib directly inhibits osteoclast function in multiple myeloma: implications into the management of myeloma bone disease
Comment on
-
Pulse treatment with the proteasome inhibitor bortezomib inhibits osteoclast resorptive activity in clinically relevant conditions.Leuk Res. 2008 Nov;32(11):1661-8. doi: 10.1016/j.leukres.2008.02.019. Epub 2008 Apr 18. Leuk Res. 2008. PMID: 18394701
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
